Recall: Heart Drugs Contain Carcinogens
Bloomberg reports that dozens of lawsuits have been filed against drug makers and sellers over widely prescribed generic heart medications tainted with potential carcinogens. A recall overseen by the U.S. Food and Drug Administration involved drugs used to treat high blood pressure, heart failure and other conditions. The lawsuits allege the plaintiffs were prescribed the medications and developed cancer according to filings in the U.S. District Court in New Jersey. In July 2018, the carcinogen NDMA was discovered in valsartan manufactured by Zhejiang Huahai Pharmaceutical Co.
|Date||Brand Name||Product Description||Reason/ Problem||Company|
|03/01/2019||Aurobindo, Acetris||Valsartan and Amlodipine and Valsartan tablets||Contains N-nitrosodiethylamine (NDEA),||AurobindoPharma USA, Inc.|
|12/31/2018||Aurobindo||Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets USP, Valsartan Tablets USP||Undeclared N-nitrosodiethylamine (NDEA)||Aurobindo Pharma USA, Inc.|
|12/04/2018||Mylan||Valsartan-containing products||Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Found in the Active Pharmaceutical Ingredient||Mylan Pharmaceuticals|
|11/27/2018||Teva Pharmaceuticals||Amlodipine/Valsartan Combination Tables and Amlopidine/Valsartan/Hydrochlorothiazide Combination Tablets||Impurity N-nitroso-diethylamine (NDEA) in API||Teva Pharmaceuticals|
|11/20/2018||Mylan||Amlodipine and Valsartan Tablets; Valsartan Tablets; Valsartan and Hydrochlorothiazide Tablets||Contain trace amounts of an impurity, N-nitrosodiethylamine (NDEA)||Mylan Pharmaceuticals|
|08/23/2018||Torrent Pharmaceuticals Limited||Valsartan/Amlodipine/HCTZ; Valsartan/Amlodipine; and Valsartan tablets||Impurity detected in the API is N-nitrosodimethylamine (NDMA)||Torrent Pharmaceuticals Limited|
|08/17/2018||Torrent||Valsartan/Amlodipine/HCTZ Tablets||Impurity detected in the API is N-nitrosodimethylamine (NDMA)||Torrent Pharmaceuticals|
|08/08/2018||Camber Pharmaceuticals, Inc.||Valsartan Tablets, USP, 40mg, 80mg, 160mg and 320mg||Detection of trace amounts of N-Nitrosodimethylamine (NDMA)||Camber Pharmaceuticals, Inc.|
|07/17/2018||Actavis||Valsartan and Valsartan Hydrochlorothiazide Tablets||Impurity detected in the API is Nnitrosodimethylamine (NDMA)||Teva Pharmaceuticals USA|
|07/17/2018||Prinston Pharmaceutical Inc. dba Solco Healthcare LLC||Valsartan Tablets, 40 mg, 80mg, 160mg, and 320mg; and Valsartan-Hydrochlorothiazide Tablets, 80mg/12.5mg, 160mg/12.5mg, 160mg/25mg, 320mg/12.5mg, and 320mg/25mg||Detection of a Trace Amount of Unexpected Impurity, N- nitrosodimethylamine (NDMA)||Prinston Pharmaceutical Inc. dba Solco Healthcare LLC|
If you have developed cancer after ingestion of the recalled drugs, valsartan—losartan and/or irbesartan, contact us for a free consultation at 1-800-814-4540 or email email@example.com. Do not stop taking your drugs without consulting your doctor and getting approval. Time limits apply so contact us now before your time runs out.